← back to search

Ziwei Huang

Chinese University of Hong Kong · CN
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Chemokine receptors and signaling, Cell death mechanisms and regulation, Immunotherapy and Immune Responses, and HIV Research and Treatment.
h-index
41
citations
9,526
works
191
NIH funding
primary concept
email

Recent publications

Structural mechanisms underlying the modulation of CXCR4 by diverse small-molecule antagonists
Proceedings of the National Academy of Sciences 2025cited by 7position: middledoi
Palmitic acid enhances the sensitivity of ferroptosis via endoplasmic reticulum stress mediated the ATF4/TXNIP Axis in polycystic ovary syndrome
Phytomedicine 2025cited by 7position: middledoi
Discovery of a potent covalent inhibitor that unusually distorts the catalytic dyad of SARS-CoV-2 main protease
Journal of Virology 2025cited by 3position: lastdoi
Structure-guided discovery of a small molecule inhibitor of SARS-CoV-2 main protease with potent <i>in vitro</i> and <i>in vivo</i> antiviral activities
Journal of Virology 2025cited by 1position: middledoi
Sulfonation metabolism in the gut microbiota is the main metabolic pathway of cholesterol in hypercholesterolemic mice
Food & Function 2024cited by 9position: middledoi
Xinbao pill attenuated water retention by regulating the CaSR/AQP2 pathway in LAD-induced chronic heart failure rats
Journal of Traditional and Complementary Medicine 2024cited by 1position: middledoi
A Chemical Strategy for the Degradation of the Main Protease of SARS-CoV-2 in Cells
Journal of the American Chemical Society 2023cited by 34position: lastdoi
Xinbao Pill attenuated chronic heart failure by suppressing the ubiquitination of β-adrenergic receptors
Phytomedicine 2023cited by 22position: middledoi
Camellia oleifera Oil Body as a Delivery System for Curcumin: Encapsulation, Physical, and in Vitro Digestion Properties
Food Biophysics 2023cited by 11position: firstdoi
Potential Therapeutic Strategies for Skeletal Muscle Atrophy
Antioxidants 2022cited by 97position: middledoi
Transcriptome Analysis of Immune Receptor Activation and Energy Metabolism Reduction as the Underlying Mechanisms in Interleukin-6-Induced Skeletal Muscle Atrophy
Frontiers in Immunology 2021cited by 42position: middledoi
Inhibition of IL-6/JAK/STAT3 pathway rescues denervation-induced skeletal muscle atrophy
Annals of Translational Medicine 2020cited by 108position: firstdoi
Isoquercitrin Delays Denervated Soleus Muscle Atrophy by Inhibiting Oxidative Stress and Inflammation
Frontiers in Physiology 2020cited by 92position: middledoi
Aspirin alleviates denervation-induced muscle atrophy via regulating the Sirt1/PGC-1α axis and STAT3 signaling
Annals of Translational Medicine 2020cited by 42position: middledoi
Discoveries and developments of CXCR4-targeted HIV-1 entry inhibitors
Experimental Biology and Medicine 2020cited by 25position: middledoi
Microarray Analysis of Gene Expression Provides New Insights Into Denervation-Induced Skeletal Muscle Atrophy
Frontiers in Physiology 2019cited by 110position: middledoi
Skeletal Muscle Atrophy Was Alleviated by Salidroside Through Suppressing Oxidative Stress and Inflammation During Denervation
Frontiers in Pharmacology 2019cited by 75position: firstdoi
PQQ ameliorates skeletal muscle atrophy, mitophagy and fiber type transition induced by denervation via inhibition of the inflammatory signaling pathways
Annals of Translational Medicine 2019cited by 68position: middledoi
miR-125b-5p targeting TRAF6 relieves skeletal muscle atrophy induced by fasting or denervation
Annals of Translational Medicine 2019cited by 54position: middledoi
High affinity CXCR4 inhibitors generated by linking low affinity peptides
European Journal of Medicinal Chemistry 2019cited by 11position: middledoi
Discovery and Computational Analyses of Novel Small Molecule Zika Virus Inhibitors
Molecules 2019cited by 9position: middledoi
Strategies and potential therapeutic agents to counter skeletal muscle atrophy
Biotarget 2018cited by 17position: firstdoi
Virtual Screening, Biological Evaluation, and 3D-QSAR Studies of New HIV-1 Entry Inhibitors That Function via the CD4 Primary Receptor
Molecules 2018cited by 9position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hualin Sun · Nantong University10 papers (2018–2022)Jing An · University of California San Diego7 papers (2018–2025)Jianwei Zhu · Nantong University6 papers (2018–2020)Yuntian Shen · Hsin Sheng College of Medical Care and Management6 papers (2019–2022)Wenjing Ma · Nantong University5 papers (2018–2020)Fei Ding · Nantong University5 papers (2019–2020)Yan Xu · University of California System5 papers (2018–2025) · 4 papers (2023–2025)Chaozai Zhang · Jilin University4 papers (2018–2020)Lilei Zhang · Nantong University3 papers (2020–2021)Jiao Zhou · Sichuan University3 papers (2019–2025)Jiao Zhou · Hunan Institute of Science and Technology3 papers (2023–2025)Robert T. Schooley · American Life Science Pharmaceuticals (United States)3 papers (2018–2019)Lina Huang · University of California System3 papers (2018–2025)Xiaoming Yang · Nanjing University of Chinese Medicine3 papers (2019–2020)Xingquan Zhang · Beijing Institute of Technology3 papers (2018–2019)Betty Yuen Kwan Law · Macau University of Science and Technology3 papers (2020–2021)Xiaosong Gu · Nanjing University of Chinese Medicine3 papers (2019–2021)Qiuyu Zhang · National University of Singapore3 papers (2019–2020)Ru Zhang · Nantong University3 papers (2019–2019)